02/10/2025
Few missions are more urgent than developing treatments for deadly, treatment-resistant cancers.
That’s exactly what Cypris Therapeutics, founded by Kyle Parella, PhD, aims to do.
“Therapeutically resistant cancers like brain, pancreatic, colon, and prostate cancer claim millions of lives each year,” Parella explains. “Everyone knows someone with cancer. For those whose disease doesn’t respond to current treatments, the experience is especially grim—many die within a year of diagnosis. We’re developing therapies to help the millions of people who currently have no effective options.”
The company’s name, Cypris, is a nod to the Cypress tree—an origin with deep scientific roots. “The original molecules we used as inspiration for our treatments are found in the bark of the Cypress tree,” says Parella. “We had to modify the spelling for branding and PR purposes, but the name still reflects where we began.”
Using nature to tackle rare cancers like brain cancer supports the theory that our body can fight many things if given the right circumstances. As a new partner of Game On Glio and Write Life Media, we are thrilled to help them advance their drug development therapies.
StacheStrong Dolphins Cancer Challenge Donna Ashworth Brain Cancer Canada
Learn more at cypristx.com
https://youtu.be/CekFsPH0-PE?si=S2hhnSQguHqHpQx7
Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.